William D. McCombe - May 13, 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Financial Officer
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Stock symbol
CTKB
Transactions as of
May 13, 2024
Transactions value $
$0
Form type
4
Date filed
5/15/2024, 07:19 PM
Previous filing
Mar 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Employee Stock Option (right to buy) Award $0 +151K $0.00 151K May 13, 2024 Common Stock 151K $6.18 Direct F1
transaction CTKB Restricted Stock Units Award $0 +101K $0.00 101K May 13, 2024 Common Stock 101K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest over 4 years with 25% of the total shares underlying the option vesting on May 13, 2025 and 1/48th of the total shares subject to the option vesting each month thereafter.
F2 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F3 The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on May 18, 2025; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 3/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter; and 3/48 of the total shares underlying the RSU Award vesting on May 18, 2026 and each May 18 thereafter.